Disclosure of large shareholding

Oslo, Norway (29 March 2021) –

Reference is made to the offer document dated 8 March 2021 (the "Offer Document") for the recommended voluntary offer by Compagnie des Levures Lesaffre (the "Offeror") to acquire all outstanding shares in NattoPharma ASA ("NattoPharma" or the "Company") against a consideration in cash of NOK 35 per share (the "Offer"), and further reference is made to the stock exchange announcement dated 29 March 2021 in which the Offeror announced that the voluntary offer is completed.

Synergia Life Sciences Pvt. Ltd sold 1,360,000 shares in this tranasaction. Following this transaction Synergia Life Sciences Pvt. Ltd. will not hold any shares in NattoPharma.

***

For more information, please contact:

Robert Schrama, CFO

E-mail: robert.schrama@nattopharma.com

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities